Cleared Traditional

K960785 - LFS LIPOGEL ASSAY KIT

K960785 is an FDA 510(k) clearance for LFS LIPOGEL ASSAY KIT, manufactured by Zaxis, Inc.. The device is a Class 1 Chemistry device with product code JHO cleared through the Traditional 510(k) pathway after a 190-day FDA review.

K960785 · Zaxis, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1996
Decision
190d
Days
Class 1
Risk

K960785 is an FDA 510(k) clearance for the LFS LIPOGEL ASSAY KIT. Classified as Electrophoretic Separation, Lipoproteins (product code JHO), Class I - General Controls.

Submitted by Zaxis, Inc. (Hudson, US). The FDA issued a Cleared decision on September 3, 1996 after a review of 190 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1475 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Zaxis, Inc. devices

FDA 510(k) Submission Details - K960785

510(k) Number K960785 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 26, 1996
Decision Date September 03, 1996
Days to Decision 190 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
102d slower than avg
Panel avg: 88d · This submission: 190d
Pathway characteristics
Predicate-based equivalence.

JHO Device Classification - Class 1, General Controls

Product Code JHO Electrophoretic Separation, Lipoproteins
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1475
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JHO Electrophoretic Separation, Lipoproteins

All 24
Devices cleared under the same product code (JHO) and FDA review panel - the closest regulatory comparables to K960785.
REP 3 QUTO-FLUR CHOLESTEROL-30
K962914 · Helena Laboratories · Jan 1997
REP FLUR CHOLESTEROL-60 KIT
K964471 · Helena Laboratories · Dec 1996
RAPID ELECTROPHORESIS ANALYZER
K960571 · Helena Laboratories · Oct 1996
REP DIRECT-SEP CHOLESTEROL-15 KIT
K935162 · Helena Laboratories · Nov 1994
REP HDL/LDL-30 KIT - CAT. NO. 3220,3221,3222
K940679 · Helena Laboratories · Sep 1994
REP LIPO-8 KIT, NO. 3182/REP LIPO-16 KIT, NO. 3181
K893223 · Helena Laboratories · Jun 1989